Bone Cancer

BONE CANCER ADVISOR

HEADLINES
TREATMENT REGIMENS
DRUG INFORMATION

FEATURED CONTENT

Cancer Patients May Have Double the Risk of Breakthrough Infection After COVID-19 Vaccination

A meta-analysis suggests that patients with cancer may be twice as likely as non-cancer patients to have a breakthrough infection after being fully vaccinated.
MIBC Tumor Subtypes May Guide Neoadjuvant Chemotherapy Use

Neoadjuvant chemotherapy response rates differed among patients with genomically unstable bladder tumors, urothelial-like bladder tumors, and basal/squamous subtypes.
Do Antibiotics Affect Outcomes of Immunotherapy in Lung Cancer?

A meta-analysis revealed inferior responses, progression-free survival, and overall survival in patients exposed to antibiotics.
Controversy Prompts Another Update to NCCN Guidelines for Prostate Cancer

After physicians voiced concerns about an active surveillance recommendation, the NCCN panel revised the guidelines.
Can Quality of Life Assessments Predict PFS, OS Across Cancer Types?

Recent studies showed associations between quality of life scores and survival in lung and prostate cancer as well as renal cell carcinoma.

BONE CANCER NEWS

Radiotherapy

Most NCCN Radiotherapy Recommendations Not Backed by High-Level Evidence

November 8, 2021

Pharmacists looking at a shelf full of drugs.

Survey Reveals ‘Striking’ Barriers to Accessing High-Priority Cancer Drugs

October 27, 2021

FDA_drug approval

Crysvita Approved for Treatment of Tumor-Induced Osteomalacia

June 23, 2020

Strontium89 Now Available for Relief of Metastatic Bone Pain

February 14, 2020

A recent article is only the latest in a series of studies drawing attention to the importance of di

FDA Grants Orphan Drug Designation to BN-Brachyury for Chordoma

May 2, 2018

Next post in Bone Cancer

Bone Cancer Treatment Regimens